
Person with measles went to Whistler's Inn, Montana's restaurant in Jasper: AHS
Alberta Health Services (AHS) is warning the public of a potential measles exposure in Jasper.
The health authority said a person with measles went to the following locations:
Whistler's Inn
July 7 from 10 p.m. to July 8 at 12 p.m.
Montana's Restaurant
July 7 from 6 p.m. to 9 p.m.
Anyone who was at these locations during the specified times, who was born in or after 1970 and has fewer than two documented doses of the measles vaccine, may be at risk for developing measles, said AHS.
The exposure notice came the same day it was reported that Alberta has more measles cases than the entire United States.
As of Tuesday afternoon, there have been 1,323 measles cases since Jan. 1. One new case was reported in the north zone while eight were reported in the south zone – the health jurisdiction with the highest concentration of cases at 782.
Measles is a highly-infectious disease that can spread easily through the air.
Symptoms may include a fever of 38.3 C or higher, cough, runny nose, red eyes, and a rash that appears three to seven days after the fever starts.
If measles symptoms do develop, AHS is advising people to stay home and call the measles hotline at 1-844-944-3434 before visiting any health care provider – including your family physician or pharmacy.
AHS said that if you think you have been exposed and are not vaccinated, you may be able to receive immunization to reduce the risk of infection. A dose of the vaccine needs to be given within 72 hours of exposure to prevent infection.
Babies under one year of age, people with severely weakened immune systems, and those who are pregnant may be able to receive immunoglobulin within six days of exposure to prevent disease.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
2 hours ago
- Globe and Mail
Beyond Medical Technologies Announces Corporate Name Change to Republic Technologies
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (the " Company") is pleased to announce that it has changed its name to Republic Technologies Inc. (" Republic"), effective on July 15th, 2025. The new CUSIP for the Company's common shares will be 760801100 and the new ISIN number will be CA7608011002. The name change highlights the Company's commitment toward leveraging transformative technologies to serve the public good. Republic develops smart contract-based attestation products and operates Ethereum validators by staking ETH to confirm transactions, produce blocks, and maintain consensus within the Proof-of-Stake (PoS) system. Republic's proprietary validator infrastructure is engineered to maximize uptime, enhance network security, and contribute to the resilience of Ethereum's core protocol. To power its long-term blockchain operations, the Company maintains ETH as its primary treasury asset and seeks to scale its holdings in line with its infrastructure growth. The new name, Republic, reflects the Company's broader commitment to decentralization, transparency, and democratized access to secure systems. Inspired by the philosophical foundations of Plato's Socratic dialogue, the name signals Republic's long-term vision of building a more inclusive and equitable digital economy. The Company's common shares will continue to trade on the Canadian Securities Exchange under the ticker symbol "DOCT". The Company is in the process of updating its website, corporate materials, and regulatory filings to reflect the new name. About Republic Technologies Inc. Republic Technologies is a publicly traded technology company integrating Ethereum infrastructure into the global economy. The company develops smart contract-based products, utilizes ETH as its primary treasury asset, and operates proprietary validator infrastructure to deliver sustainable, non-dilutive value to shareholders.


CBC
4 hours ago
- CBC
What cheaper versions of Ozempic will mean for B.C.'s diabetics
In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Dr. Tom Elliott, medical director at B.C. Diabetes, says that semaglutide injections have revolutionized his practice, and they are astonishingly effective.

CTV News
5 hours ago
- CTV News
CTV National News: Alberta reporting more measles cases than all of the U.S.
Watch Some Alberta hospitals say the province's measles outbreak has forced them to triage patients in parking lots. Kathy Le on the surge in cases.